The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
The Process of Structure-Based Drug Design
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
WHAT IF: A molecular modeling and drug design program
Vriend, G. (1990) · Journal of Molecular Graphics · doi:10.1016/0263-7855(90)80070-v · Cited by 3,469
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
Pervushin, K., Riek, R., Wider, G., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,445
A geometric approach to macromolecule-ligand interactions
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90153-x · Cited by 2,278
The Structural Basis of Ribosome Activity in Peptide Bond Synthesis
Nissen, P., Hansen, J., Ban, N., Moore, P. B., & Steitz, T. A. (2000) · Science · doi:10.1126/science.289.5481.920 · Cited by 2,269
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Abagyan, R., Totrov, M., & Kuznetsov, D. (1994) · Journal of Computational Chemistry · doi:10.1002/jcc.540150503 · Cited by 1,699
Automated docking of flexible ligands: Applications of autodock
Goodsell, D. S., Morris, G. M., & Olson, A. J. (1996) · Journal of Molecular Recognition · doi:10.1002/(sici)1099-1352(199601)9:1<1::aid-jmr241>3.0.co;2-6 · Cited by 1,582
Traitement statistique des erreurs dans la determination des structures cristallines
Luzzati, V. (1952) · Acta Crystallographica · doi:10.1107/s0365110x52002161 · Cited by 1,251
DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
Ewing, T. J. A., Makino, S., Skillman, A. G., & Kuntz, I. D. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011115820450 · Cited by 1,187
The penultimate rotamer library
Lovell, S. C., Word, J. M., Richardson, J. S., & Richardson, D. C. (2000) · Proteins: Structure, Function, and Genetics · doi:10.1002/1097-0134(20000815)40:3<389::aid-prot50>3.0.co;2-2 · Cited by 1,036
PERVUSHIN, K., RIEK, R., WIDER, G., & WÜTHRICH, K. (2021) · NMR with Biological Macromolecules in Solution · doi:10.1142/9789811235795_0006 · Cited by 951
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., et al. (1990) · Science · doi:10.1126/science.2183354 · Cited by 929
The computer program LUDI: A new method for the de novo design of enzyme inhibitors
B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124387 · Cited by 835
Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors
Lam, P. Y. S., Jadhav, P. K., Eyermann, C. J., Hodge, C. N., Ru, Y., Bacheler, L. T., Meek, J. L., Otto, M. J., Rayner, M. M., Wong, Y. N., et al. (1994) · Science · doi:10.1126/science.8278812 · Cited by 834
A review of protein-small molecule docking methods
Taylor, R. D., Jewsbury, P. J., & Essex, J. W. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020155510718 · Cited by 655
Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease
Kaldor, S. W., Kalish, V. J., Davies, J. F., Shetty, B. V., Fritz, J. E., Appelt, K., Burgess, J. A., Campanale, K. M., Chirgadze, N. Y., Clawson, D. K., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9704098 · Cited by 618
Functionality maps of binding sites: A multiple copy simultaneous search method
Miranker, A., & Karplus, M. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110104 · Cited by 544
Erickson, J., Neidhart, D. J., VanDrie, J., Kempf, D. J., Wang, X. C., Norbeck, D. W., Plattner, J. J., Rittenhouse, J. W., Turon, M., Wideburg, N., et al. (1990) · Science · doi:10.1126/science.2200122 · Cited by 527
QXP: Powerful, rapid computer algorithms for structure-based drug design
Mcmartin, C., & Bohacek, R. S. (1997) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1007907728892 · Cited by 510
Lead discovery using molecular docking
Shoichet, B. K., McGovern, S. L., Wei, B., & Irwin, J. J. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00339-3 · Cited by 501
Böhm, H.-J. (1998) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1007999920146 · Cited by 431
FlexE: efficient molecular docking considering protein structure variations
Claußen, H., Buning, C., Rarey, M., & Lengauer, T. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4551 · Cited by 430
Pellecchia, M., Sem, D. S., & Wüthrich, K. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd748 · Cited by 420
L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor
Dorsey, B. D., Levin, R. B., McDaniel, S. L., Vacca, J. P., Guare, J. P., Darke, P. L., Zugay, J. A., Emini, E. A., & Schleif, W. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00047a001 · Cited by 412
Molecular docking to ensembles of protein structures 1 1Edited by B. Honig
Knegtel, R. M. A., Kuntz, I. D., & Oshiro, C. M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0776 · Cited by 392
Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites
Welch, W., Ruppert, J., & Jain, A. N. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90093-9 · Cited by 365
Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis
Davis, A. M., & Teague, S. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990315)38:6<736::aid-anie736>3.0.co;2-r · Cited by 333
Structure-based drug design: progress, results and challenges
Verlinde, C. L., & Hol, W. G. (1994) · Structure · doi:10.1016/s0969-2126(00)00060-5 · Cited by 331
Accommodating Protein Flexibility in Computational Drug Design,
Carlson, H. A., & McCammon, J. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23192-8 · Cited by 324
Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer Screening
Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010016f · Cited by 315
Protein flexibility and drug design: how to hit a moving target
Carlson, H. A. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00341-1 · Cited by 314
Targeting RNA with Small-Molecule Drugs: Therapeutic Promise and Chemical Challenges
Gallego, J., & Varani, G. (2001) · Accounts of Chemical Research · doi:10.1021/ar000118k · Cited by 304
Flexible ligand docking using conformational ensembles
Lorber, D. M., & Shoichet, B. K. (1998) · Protein Science · doi:10.1002/pro.5560070411 · Cited by 295
Ligand solvation in molecular docking
Shoichet, B. K., Leach, A. R., & Kuntz, I. D. (1999) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(19990101)34:1<4::aid-prot2>3.0.co;2-6 · Cited by 290
DeWitte, R. S., & Shakhnovich, E. I. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960751u · Cited by 262
Developing a Dynamic Pharmacophore Model for HIV-1 Integrase
Carlson, H. A., Masukawa, K. M., Rubins, K., Bushman, F. D., Jorgensen, W. L., Lins, R. D., Briggs, J. M., & McCammon, J. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990322h · Cited by 259
A multiple‐start Monte Carlo docking method
Hart, T. N., & Read, R. J. (1992) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340130304 · Cited by 227
Computer design of bioactive molecules: A method for receptor‐based de novo ligand design
Moon, J. B., & Howe, W. J. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110409 · Cited by 223
Eisen, M. B., Wiley, D. C., Karplus, M., & Hubbard, R. E. (1994) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340190305 · Cited by 210
Caflisch, A., Miranker, A., & Karplus, M. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00067a013 · Cited by 208
SPROUT: A program for structure generation
Gillet, V., Johnson, A. P., Mata, P., Sike, S., & Williams, P. (1993) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00126441 · Cited by 195
GroupBuild: a fragment-based method for de novo drug design
Rotstein, S. H., & Murcko, M. A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00064a003 · Cited by 192
Bohacek, R. S., & McMartin, C. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00092a006 · Cited by 188
MCDOCK: A Monte Carlo simulation approach to the molecular docking problem
Liu, M., & Wang, S. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008005918983 · Cited by 173
Structure-Based Approach for Binding Site Identification on AmpC β-Lactamase
Powers, R. A., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020002p · Cited by 138
GenStar: A method for de novo drug design
Rotstein, S. H., & Murcko, M. A. (1993) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00141573 · Cited by 133
Rational Automatic Search Method for Stable Docking Models of Protein and Ligand
Mizutani, M., Tomioka, N., & Itai, A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1656 · Cited by 130
Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129
Structure-Based Discovery of a Novel, Noncovalent Inhibitor of AmpC β-Lactamase
Powers, R. A., Morandi, F., & Shoichet, B. K. (2002) · Structure · doi:10.1016/s0969-2126(02)00799-2 · Cited by 121
Small molecule antagonists of proteins
Gadek, T. R., & Nicholas, J. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01479-x · Cited by 120
Method for Including the Dynamic Fluctuations of a Protein in Computer-Aided Drug Design
Carlson, H. A., Masukawa, K. M., & McCammon, J. A. (1999) · The Journal of Physical Chemistry A · doi:10.1021/jp991997z · Cited by 117
CONCERTS: Dynamic Connection of Fragments as an Approach to de Novo Ligand Design
Pearlman, D. A., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950792l · Cited by 116
Varney, M. D., Marzoni, G. P., Palmer, C. L., Deal, J. G., Webber, S., Welsh, K. M., Bacquet, R. J., Bartlett, C. A., & Morse, C. A. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00082a006 · Cited by 116
Quality assessment of NMR structures: a statistical survey
Doreleijers, J. F., Rullmann, J. A. C., & Kaptein, R. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1808 · Cited by 105
Prodock: Software package for protein modeling and docking
Trosset, J., & Scheraga, H. A. (1999) · Journal of Computational Chemistry · Cited by 103
Energetic and Entropic Factors Determining Binding Affinity in Protein-Ligand Complexes
Klebe, G., & Böhm, H. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036621 · Cited by 102
Computational approaches to structure-based ligand design
Joseph‐McCarthy, D. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00031-5 · Cited by 101
Efficient electrostatic solvation model for protein-fragment docking
Majeux, N., Scarsi, M., & Caflisch, A. (2000) · Proteins Structure Function and Bioinformatics · Cited by 97
Nishibata, Y., & Itai, A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00072a011 · Cited by 94
An automated method for dynamic ligand design
Miranker, A. D., & Karplus, M. (1995) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340230403 · Cited by 91
Structure-Based Approach for the Discovery of Bis-benzamidines as Novel Inhibitors of Matriptase
Enyedy, I. J., Lee, S.-L., Kuo, A. H., Dickson, R. B., Lin, C., & Wang, S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000395x · Cited by 80
Choosing anticancer drug targets in the postgenomic era
Kaelin, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8888 · Cited by 79
Anderson, A. C., O’Neil, R. H., Surti, T. S., et al. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00023-0 · Cited by 76
Self-citationDevelopment of neuraminidase inhibitors as anti-influenza virus drugs
Varghese, J. N. (1999) · Drug Development Research · Cited by 75
Altered affinity of CBFβ-SMMHC for Runx1 explains its role in leukemogenesis
Lukasik, S. M., Zhang, L., Corpora, T., Tomanicek, S., Li, Y., Kundu, M., Hartman, K. L., Liu, P., Laue, T. M., Biltonen, R. L., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb831 · Cited by 69
Crystal Structure of the Complex between VEGF and a Receptor-Blocking Peptide
Wiesmann, C., Christinger, H. W., Cochran, A. G., Cunningham, B. C., Fairbrother, W. J., Keenan, C. J., Meng, G., & de Vos, A. M. (1998) · Biochemistry · doi:10.1021/bi9819327 · Cited by 67
Rutenber, E. E., & Stroud, R. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00139-6 · Cited by 67
Automated protein fold determination using a minimal NMR constraint strategy
Zheng, D., Huang, Y. J., Moseley, H., Xiao, R., Aramini, J. M., Swapna, G. V. T., & Montelione, G. T. (2003) · Protein Science · doi:10.1110/ps.0300203 · Cited by 57
In silico discovery of novel Retinoic Acid Receptor agonist structures
Schapira, M., Raaka, B. M., Samuels, H. H., & Abagyan, R. A. (2001) · BMC Structural Biology · doi:10.1186/1472-6807-1-1 · Cited by 54
Stout, T. J., & Stroud, R. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00010-x · Cited by 38
Significance of structural changes in proteins: Expected errors in refined protein structures
Stroud, R. M., & Fauman, E. B. (1995) · Protein Science · doi:10.1002/pro.5560041118 · Cited by 34
Fritz, T. A., Tondi, D., Finer-Moore, J. S., Costi, M. P., & Stroud, R. M. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00067-9 · Cited by 32
Goedken, E. R., & Marqusee, S. (1998) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19981001)33:1<74::aid-prot7>3.0.co;2-l · Cited by 11
Cited by
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Krishnamurthy, V. M., Kaufman, G. K., Urbach, A. R., Gitlin, I., Gudiksen, K. L., Weibel, D. B., & Whitesides, G. M. (2008) · Chemical Reviews · doi:10.1021/cr050262p · Cited by 761
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762
A Structure-Based Drug Discovery Paradigm
Batool, M., Ahmad, B., & Choi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112783 · Cited by 744
Metadata
- Authors
- Anderson, A. C.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 10
- Issue
- 9
- Pages
- 787-797
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W1975447903
- Cited by
- 939
- References
- 81
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.